Post by AbbVie on X
AbbVie@abbvie
XNEWS: We shared topline results from our Phase 3 trial in adult patients with relapsed/refractory diffuse large B-cell #lymphoma (#DLBCL), in partnership with @Genmab. Learn more: t.co
9 likes1 repliesPosted Jun 30, 2026